Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

LNK can also be mutated outside PH and SH2 domains in myeloproliferative neoplasms with and without V617FJAK2 mutation.

Leukemia research - 1 Nov 2011

Hurtado C, Erquiaga I, Aranaz P, Miguéliz I, García-Delgado M, Novo F J, Vizmanos J L

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adaptor Proteins, Signal Transducing
Share to Blood Proteins
Share to Intracellular Signaling Peptides and Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Janus Kinase 2

Share to Myeloproliferative Disorders

Share to Phosphoproteins

Share to Proteins

Share to src Homology Domains

Source

Identifiers

PMID: 21794913
DOI: 10.1016/j.leukres.2011.07.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

LNK can also be mutated outside PH and SH2 domains in myeloproliferative neoplasms with and without V617FJAK2 mutation.PMID 21794913Read ↗

Possible new LNK mutations in myeloproliferative neoplasms.Semantic proximity Read ↗

[Role of LNK gene mutation in pathogenesis of myeloproliferative neoplasms-review].Semantic proximity Read ↗

The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders.Semantic proximity Read ↗

LNK mutations in JAK2 mutation-negative erythrocytosis.Semantic proximity Read ↗

The Polymorphisms in LNK Gene Correlated to the Clinical Type of Myeloproliferative Neoplasms.Semantic proximity Read ↗

Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasmsSemantic proximity Read ↗

LNK mutations and myeloproliferative disorders.Semantic proximity Read ↗

SH2B3 (LNK) mutations from myeloproliferative neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617F.Semantic proximity Read ↗

The Lnk adaptor protein: a key regulator of normal and pathological hematopoiesis.Semantic proximity Read ↗

LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations.Semantic proximity Read ↗

Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617FSemantic proximity Read ↗

Expression level and differential JAK2-V617F-binding of the adaptor protein Lnk regulates JAK2-mediated signals in myeloproliferative neoplasms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.